Basics Embecta Corp. IPO Date: April 1, 2022 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $610.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.19% Avg Daily Range (30 D): $0.35 | 2.97% Avg Daily Range (90 D): $0.36 | 2.70% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .45M Avg Daily Volume (90 D): .44M Trade Size Avg Trade Size (Sh.): 61 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 57 Institutional Trades Total Inst.Trades: 1,289 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $1.2M Avg Inst. Trade (90 D): $1.45M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.56M Avg Closing Trade (30 D): $1.16M Avg Closing Trade (90 D): $1.49M Avg Closing Volume: 112.83K     News May 27, 2025 @ 9:00 PM embecta to Participate in Investor Events Source: N/A May 9, 2025 @ 10:00 AM embecta Announces Quarterly Cash Dividend Source: N/A Apr 21, 2025 @ 9:00 PM embecta to Report Fiscal Second Quarter 2025 Finan... Source: N/A Feb 18, 2025 @ 10:00 PM embecta to Participate at the J.P. Morgan Global L... Source: N/A Feb 6, 2025 @ 3:24 PM Becton Dickinson Q1 Earnings: Revenue And EPS Beat... Source: Vandana Singh Financials   TTM Q1 2025 Q4 2024 Basic EPS $.4 $ $.25 Diluted EPS $.4 $ $.24 Revenue $ 259M $ 261.9M $ 286.1M Gross Profit $ 164.1M $ 157.1M $ 173.8M Net Income / Loss $ 23.5M $ M $ 14.6M Operating Income / Loss $ 62.9M $ 28.7M $ 26.2M Cost of Revenue $ 94.9M $ 104.8M $ 112.3M Net Cash Flow $ $ $ -10M PE Ratio 0.00